Hochschulschrift
Identification and characterization of adaptive immune responses to H3K27M peptide vaccination in diffuse midline glioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
IX, 83 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Ruprecht-Karls-University Heidelberg, Dissertation, 2024
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2024]
Ähnliche Objekte (12)
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma